129 related articles for article (PubMed ID: 23728754)
21. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
22. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain).
Peris M; Espinàs JA; Muñoz L; Navarro M; Binefa G; Borràs JM;
J Med Screen; 2007; 14(2):81-6. PubMed ID: 17626707
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the occult blood test in screening for colorectal neoplasms. A prospective study using flexible endoscopy.
Reilly JM; Ballantyne GH; Fleming FX; Zucker KA; Modlin IM
Am Surg; 1990 Mar; 56(3):119-23. PubMed ID: 2316930
[TBL] [Abstract][Full Text] [Related]
24. Excellent performance of Hemoccult Sensa in organised colorectal cancer screening.
Kershenbaum A; Flugelman A; Lejbkowicz F; Arad H; Rennert G
Eur J Cancer; 2013 Mar; 49(4):923-30. PubMed ID: 23099005
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of usefulness of faecal occult blood test. Prospective screening study in patients with colorectal neoplasia].
Banaszkiewicz Z; Jawień A; Jarmocik P; Tojek K; Jankowski M; Switoński M
Pol Merkur Lekarski; 2004 Dec; 17(102):579-82. PubMed ID: 15771126
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.
Hamza S; Dancourt V; Lejeune C; Bidan JM; Lepage C; Faivre J
Eur J Cancer; 2013 Aug; 49(12):2727-33. PubMed ID: 23601670
[TBL] [Abstract][Full Text] [Related]
27. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
28. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening.
Raginel T; Puvinel J; Ferrand O; Bouvier V; Levillain R; Ruiz A; Lantieri O; Launoy G; Guittet L
Gastroenterology; 2013 May; 144(5):918-25. PubMed ID: 23376426
[TBL] [Abstract][Full Text] [Related]
29. Immunological faecal occult blood testing: a discriminatory test to identify colorectal cancer in symptomatic patients.
Kaul A; Shah A; Magill FH; Hawkins SA; Skaife P
Int J Surg; 2013; 11(4):329-31. PubMed ID: 23459187
[TBL] [Abstract][Full Text] [Related]
30. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.
Faivre J; Dancourt V; Manfredi S; Denis B; Durand G; Gendre I; Bidan JM; Jard C; Levillain R; Jung S; Viguier J; Dorval E
Dig Liver Dis; 2012 Aug; 44(8):700-4. PubMed ID: 22542582
[TBL] [Abstract][Full Text] [Related]
31. A Questionnaire Survey on the Sequence of Events Prior to Undergoing Colonoscopy: The Influence of the Behavioral Response after a Fecal Occult Blood Test on the Early Detection of Colorectal Cancer.
Yuge R; Fujii T; Shinagawa K; Sanomura Y; Oka S; Nagashima S; Ohisa M; Kitadai Y; Tanaka S; Kohno N; Tanaka J
Intern Med; 2019 Jun; 58(11):1541-1547. PubMed ID: 30713310
[TBL] [Abstract][Full Text] [Related]
32. Effect of faecal occult blood positivity on detection rates and positive predictive value of CT colonography when screening for colorectal neoplasia.
Plumb AA; Taylor SA; Halligan S
Clin Radiol; 2015 Oct; 70(10):1104-9. PubMed ID: 26145187
[TBL] [Abstract][Full Text] [Related]
33. The positive predictive value of guaiac faecal occult blood test in relation to the number of positive squares in two consecutive rounds of colorectal cancer screening.
Manfredi S; Philip J; Campillo B; Piette C; Durand G; Riou F; Bretagne JF
Eur J Cancer Prev; 2011 Jul; 20(4):277-82. PubMed ID: 21633201
[TBL] [Abstract][Full Text] [Related]
34. Findings of diagnostic colonoscopy in young adults versus findings of screening colonoscopy in patients aged 50 to 54 years: a comparative study stratified by symptom category.
Cha JM; Kozarek RA; La Selva D; Gluck M; Ross A; Chiorean M; Koch J; Lin OS
Gastrointest Endosc; 2015 Jul; 82(1):138-45. PubMed ID: 25843617
[TBL] [Abstract][Full Text] [Related]
35. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
36. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
37. The role of faecal calprotectin in the identification of colorectal neoplasia in patients attending for screening colonoscopy.
Ross FA; Park JH; Mansouri D; Little C; Di Rollo DG; Combet E; Van Wyk H; Horgan PG; McMillan DC; Roxburgh CSD
Colorectal Dis; 2022 Feb; 24(2):188-196. PubMed ID: 34614299
[TBL] [Abstract][Full Text] [Related]
38. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
Brenner H; Tao S
Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
[TBL] [Abstract][Full Text] [Related]
39. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
[TBL] [Abstract][Full Text] [Related]
40. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test.
Denis B; Ruetsch M; Strentz P; Vogel JY; Guth F; Boyaval JM; Pagnon X; Ebelin JF; Gendre I; Perrin P
Gut; 2007 Nov; 56(11):1579-84. PubMed ID: 17616542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
